ATIP vs. AIM, FBRX, MEIP, LYRA, BSGM, LUMO, IBIO, NRXS, ZIVO, and INDP
Should you be buying ATI Physical Therapy stock or one of its competitors? The main competitors of ATI Physical Therapy include AIM ImmunoTech (AIM), Forte Biosciences (FBRX), MEI Pharma (MEIP), Lyra Therapeutics (LYRA), BioSig Technologies (BSGM), Lumos Pharma (LUMO), iBio (IBIO), NeurAxis (NRXS), ZIVO Bioscience (ZIVO), and Indaptus Therapeutics (INDP). These companies are all part of the "medical" sector.
AIM ImmunoTech (NYSE:AIM) and ATI Physical Therapy (NYSE:ATIP) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, community ranking, risk, earnings, valuation and institutional ownership.
AIM ImmunoTech has higher earnings, but lower revenue than ATI Physical Therapy. AIM ImmunoTech is trading at a lower price-to-earnings ratio than ATI Physical Therapy, indicating that it is currently the more affordable of the two stocks.
12.0% of AIM ImmunoTech shares are held by institutional investors. Comparatively, 72.6% of ATI Physical Therapy shares are held by institutional investors. 0.0% of AIM ImmunoTech shares are held by insiders. Comparatively, 3.3% of ATI Physical Therapy shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
AIM ImmunoTech has a beta of -0.11, indicating that its share price is 111% less volatile than the S&P 500. Comparatively, ATI Physical Therapy has a beta of 0.34, indicating that its share price is 66% less volatile than the S&P 500.
ATI Physical Therapy has a net margin of -8.15% compared to ATI Physical Therapy's net margin of -16,123.32%. AIM ImmunoTech's return on equity of 0.00% beat ATI Physical Therapy's return on equity.
In the previous week, AIM ImmunoTech had 4 more articles in the media than ATI Physical Therapy. MarketBeat recorded 4 mentions for AIM ImmunoTech and 0 mentions for ATI Physical Therapy. AIM ImmunoTech's average media sentiment score of 0.00 beat ATI Physical Therapy's score of -1.50 indicating that ATI Physical Therapy is being referred to more favorably in the news media.
AIM ImmunoTech received 41 more outperform votes than ATI Physical Therapy when rated by MarketBeat users. Likewise, 82.35% of users gave AIM ImmunoTech an outperform vote while only 36.59% of users gave ATI Physical Therapy an outperform vote.
Summary
ATI Physical Therapy beats AIM ImmunoTech on 9 of the 15 factors compared between the two stocks.
Get ATI Physical Therapy News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATIP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ATIP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ATI Physical Therapy Competitors List
Related Companies and Tools
